Stocklytics Platform
Asset logo for symbol OCS
Oculis Holding AG - Ordinary shares
OCS53
$22.44arrow_drop_up0.26%$0.06
Asset logo for symbol OCS
OCS53

$22.44

arrow_drop_up0.26%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Oculis Holding AG - Ordinary shares (OCS) Stocklytics Forecast

Oculis Holding AG (OCS) is a company that develops and commercializes innovative therapies for ophthalmic diseases. With a focus on ocular surface diseases, Oculis aims to provide effective treatments to improve patients' vision and quality of life. The company's ordinary shares (OCS) are traded on the stock market, and investors are often interested in predicting the future stock price and making informed investment decisions.
While it is challenging to accurately predict the future stock price of Oculis Holding AG, various tools and techniques can aid in making forecasts. AI price prediction models and machine learning algorithms are commonly used to analyze historical stock data, market trends, and other relevant factors. These models can provide insights into potential future price movements based on patterns and correlations detected in the data.
add Oculis Holding AG - Ordinary shares to watchlist

Keep an eye on Oculis Holding AG - Ordinary shares

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Oculis Holding AG - Ordinary shares (OCS) stock?

Analysts have set a target price of $30.19 for Oculis Holding AG - Ordinary shares (OCS), based on forecasts from 21 analysts. The predicted price range extends from a high of $58 to a low of $20. This represents a potential increase of up to 158.47% and a decrease of -10.87% from the current price of $22.44. These forecasts are as of 2023 Apr 28.
help

What are the analyst ratings for Oculis Holding AG - Ordinary shares (OCS) stock?

The analyst ratings for Oculis Holding AG - Ordinary shares (OCS) are distributed as follows: 7 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Oculis Holding AG - Ordinary shares.
help

What is the AI price prediction for Oculis Holding AG - Ordinary shares (OCS) stock?

At present, there is no AI or machine-learning-based price prediction available for Oculis Holding AG - Ordinary shares (OCS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level